Regulatory discussions about nicotine pouches and youth access have focused primarily on the legal market — the products sold in retailers with age verification, made by companies with compliance teams, and subject to whatever labelling and marketing restrictions apply in the relevant jurisdiction. This focus, while understandable, may be directing attention and regulatory energy away from the part of the market that presents the most significant youth risk: the unregulated, often illegal products that operate outside any compliance framework.
Ultra-strength pouches — products containing 50mg, 100mg, or even higher nicotine concentrations — are available through online channels that operate outside normal retail regulation. These products are not subject to the age verification requirements, marketing restrictions, or labelling standards that apply to legal market products. Their potency presents acute risk of nicotine toxicity, particularly for inexperienced users or young people whose nicotine tolerance is lower than established adult smokers.
The irony of the current regulatory debate is that policies focused on restricting the legal market — reducing strength caps, limiting flavours, restricting marketing — may push consumers toward these unregulated products without meaningfully reducing access for the youth users who are the stated target of the restrictions. A young person who cannot buy a 4mg ZYN legally may be more likely to access a 50mg product through informal channels than to stop using nicotine altogether.
This dynamic is familiar from alcohol and drug policy, where restrictions on legal market products consistently produce informal market substitution rather than consumption reduction. The evidence from cannabis legalisation markets is particularly relevant: regulated markets with age verification consistently outperform prohibition at restricting youth access to the products in question.
Effective youth protection in the nicotine pouch space requires a two-track approach: maintaining and improving age verification and compliance in the legal market while developing enforcement capacity against the illegal high-strength products that present the greatest acute risk. The current regulatory debate is heavily weighted toward the first track and has largely ignored the second.
